141
Views
22
CrossRef citations to date
0
Altmetric
CaseReport

Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists

, , , , , & show all
Pages 137-140 | Received 20 Dec 2004, Accepted 28 Dec 2004, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elvia Yadira Velázquez-Armenta, Jung Yeol Han, June Seek Choi, Kwang Moon Yang & Alejandro A. Nava-Ocampo. (2007) Angiotensin II Receptor Blockers in Pregnancy: A Case Report and Systematic Review of the Literature. Hypertension in Pregnancy 26:1, pages 51-66.
Read now

Articles from other publishers (21)

Yuan Liu, Ruonan Zhai, Jiahao Tong, Ying Yu, Lin Yang, Yong Gu & Jianying Niu. (2022) Angiotensin 1-7 and its analogue decrease blood pressure but aggravate renal damage in preeclamptic mice. Experimental Animals 71:4, pages 519-528.
Crossref
Jessica Saunders, Allison Marie Callejas Salgado, Joseph Y Ting, Cherry Mammen, Jefferson Terry & Jonathan W Bush. (2021) Quantifying Proximal Collecting Tubule Deficiency in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Fetopathy. Pediatric and Developmental Pathology 24:5, pages 438-444.
Crossref
Mi Hyeon Gang, Yong Wook Lee & Mea-young Chang. (2021) Secondary renal tubular dysgenesis in a newborn exposed to angiotensin Ⅱ receptor antagonist during gestation. Clinical and Experimental Pediatrics 64:3, pages 136-138.
Crossref
Qiang Wei, Li Zhang, Mei-fan Duan, Yue-mei Wang, Nan Huang & Chun-rong Song. (2021) Use of angiotensin II receptor blocker during pregnancy. Medicine 100:3, pages e24304.
Crossref
Tamara Sáez, Floor Spaans, Raven Kirschenman, Tatsuya Sawamura & Sandra T. Davidge. (2020) High-cholesterol diet during pregnancy induces maternal vascular dysfunction in mice: potential role for oxidized LDL-induced LOX-1 and AT1 receptor activation. Clinical Science 134:17, pages 2295-2313.
Crossref
Jingwei Bian, Jinghui Lei, Xiaochen Yin, Pengli Wang, Ye Wu, Xiaoli Yang, Li Wang, Suli Zhang, Huirong Liu & Michael L. X. Fu. (2019) Limited AT1 Receptor Internalization Is a Novel Mechanism Underlying Sustained Vasoconstriction Induced by AT1 Receptor Autoantibody From Preeclampsia. Journal of the American Heart Association 8:6.
Crossref
Jean-Pierre Guignard & Jean-Bernard Gouyon. 2019. Nephrology and Fluid/electrolyte Physiology. Nephrology and Fluid/electrolyte Physiology 99 117 .
Fred E. Avni & Annie Lahoche. 2018. Imaging Acute Abdomen in Children. Imaging Acute Abdomen in Children 65 75 .
Chisa Shimada, Rina Akaishi, Kazutoshi Cho, Mamoru Morikawa, Yosuke Kaneshi, Takahiro Yamda & Hisanori Minakami. (2015) Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review. Hypertension Research 38:5, pages 308-313.
Crossref
Yifat Gadot & Gideon Koren. 2015. Medicines For Women. Medicines For Women 97 137 .
Ming-Yan Hei & Zhu-Wen Yi. (2014) Environmental factors for the development of fetal urinary malformations. World Journal of Pediatrics 10:1, pages 17-23.
Crossref
Florian Herse & Babbette LaMarca. (2013) Angiotensin II Type 1 Receptor Autoantibody (AT1-AA)-Mediated Pregnancy Hypertension. American Journal of Reproductive Immunology 69:4, pages 413-418.
Crossref
Marina BulloSibylle TschumiBarbara S. BucherMario G. BianchettiGiacomo D. Simonetti. (2012) Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists. Hypertension 60:2, pages 444-450.
Crossref
Janine E. Polifka. (2012) Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Research Part A: Clinical and Molecular Teratology 94:8, pages 576-598.
Crossref
Jean-Pierre Guignard & Jean-Bernard Gouyon. 2012. Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions and Controversies. Nephrology and Fluid/Electrolyte Physiology: Neonatology Questions and Controversies 117 135 .
A. Yamada, Y. Tsuji, Y. Kato & N. Ueda. (2011) Renal tubular dysgenesis and reversible hypocalvaria after intrauterine exposure to an angiotensin receptor blocker. Clinical Kidney Journal 4:2, pages 141-142.
Crossref
M.P. Carrillo, J.C. Presa, F.S. Molina, M. Valverde & A.M. Puertas. (2010) Efecto de los inhibidores de los receptores de angiotensina II en la gestación. Clínica e Investigación en Ginecología y Obstetricia 37:4, pages 166-168.
Crossref
Kaoru Kato, Mika Okuda, Hiroshi Ishikawa, Tsuneo Takahashi & Fumiki Hirahara. (2008) Oligohydramnios and pulmonary hypoplasia: A case in which involvement of an angiotensin II receptor antagonist was suspected. Journal of Obstetrics and Gynaecology Research 34:2, pages 242-246.
Crossref
Lidia Hyla-Klekot, Ewa Gacka, Barbara Pulcer, Janina Taraszkiewicz & Grażyna Kucharska. (2008) Patofizjiologiczne i komórkowe mechanizmy prenatalnego upośledzenia nefrogenezy w nefropatii zaporowej – następstwa i implikacje kliniczne. Pediatria Polska 83:2, pages 167-173.
Crossref
H. Ben Amar, A. Gargouri, S. Makni, H. Kammoun, L. Trigui, N. Hentati Hmida, M.-C. Gubler, R. Regaieg, T. Boudawara & A. Rekik. (2007) Dysgénésie tubulaire rénale autosomique récessive: étude morphologique et génétique de 2 nouveaux cas. Archives de Pédiatrie 14:9, pages 1088-1091.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:5, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.